Notice of republication
This article was republished on October 16, 2018 to correct for formatting errors in the Materials and methods, Results, and Discussion sections introduced during the typesetting process. The publisher apologizes for these errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.
Supporting information
S1 File. Originally published, uncorrected article.
https://doi.org/10.1371/journal.pone.0206719.s001
(PDF)
Reference
- 1. Oh ES, Blennow K, Bigelow GE, Inouye SK, Marcantonio ER, Neufeld KJ, et al. (2018) Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia. PLoS ONE 13(9): e0204695. https://doi.org/10.1371/journal.pone.0204695 pmid:30252906
Citation: The PLOS ONE Staff (2018) Correction: Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia. PLoS ONE 13(10): e0206719. https://doi.org/10.1371/journal.pone.0206719
Published: October 26, 2018
Copyright: © 2018 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.